Glycogen synthase kinase-3β regulates Tyr307 phosphorylation of protein phosphatase-2A via protein tyrosine phosphatase 1B but not Src

Biochemical Journal

Volumn 437, Issue 2, 2011, Pages 335-344

  Yao, Xiu Qing ^a   Zhang, Xiao Xue ^a   Yin, Yang Yang ^a   Liu, Bin ^a   Luo, Dan Ju ^a   Liu, Dan ^a   Chen, Ning Ning ^a   Ni, Zhong Fei ^a   Wang, Xiong ^a   Wang, Qun ^a   Wang, Jian Zhi ^a   Liu, Gong Ping ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Alzheimer's disease; Glycogen synthase kinase 3 (GSK 3 ); Phosphorylation; Protein phosphatase 2A (PP2A); Protein tyrosine phosphatase 1B (PTP1B); Tau

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; MESSENGER RNA; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN SRC; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE 1B; SMALL INTERFERING RNA; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SRC HOMOLOGY DOMAIN;

ANDROSTADIENES; ANIMALS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; GLYCOGEN SYNTHASE KINASE 3; HEK293 CELLS; HUMANS; INDOLES; MALEIMIDES; MICE; MICE, INBRED C57BL; PROTEIN PHOSPHATASE 2; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; RATS; RNA, MESSENGER; SERINE; SRC-FAMILY KINASES; TAU PROTEINS; TRANSCRIPTION, GENETIC; TYROSINE;

EID: 79959736543     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20110347     Document Type: Article

References (66)

1. Grundke-Iqbal, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S. and Wisniewski, H. M. (1986) Microtubule-associated protein tau: a component of Alzheimer paired helical filament. J. Biol. Chem. 261, 6084-6089
2. Lee, V. M., Balin, B. J., Otvos, L. J. and Trojanowski, J. Q. (1991) A68: a major subunit of the paired helical filaments and derivatized forms of normal tau. Science 251, 675-678
3. Hanger, D. P., Seereeram, A. and Noble, W. (2009) Mediators of tau phosphorylation in the pathogenesis of Alzheimer's disease. Expert Rev. Neurother. 9, 1647-1666
4. Hanger, D. P., Anderton, B. H. and Noble, W. (2009) Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. Trends Mol. Med. 15, 112-119
5. Takashima, A. (2006) GSK-3 is essential in the pathogenesis of Alzheimer's disease. J. Alzheimers Dis. 9, 309-317
6. Planel, E., Miyasaka, T., Launey, T., Chui, D. H., Tanemura, K., Sato, S., Murayama, O., Ishiguro, K., Tatebayashi, Y and Takashima, A. (2004) Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease. J. Neurosci. 4, 2401-2411 (Pubitemid 38327953)
7. Iqbal, K., Liu, F., Gong, C. X., Alonso Adel, C. and Grundke-Iqbal, I. (2009) Mechanisms of tau-induced neurodegeneration. Acta Neuropathol. 118, 53-69
8. Wang, J. Z. and Liu, F. (2008) Microtubule-associated protein tau in development, degeneration and protection of neurons. Prog. Neurobiol. 85, 148-175
9. Ishiguro, K., Omori, A., Takamatsu, M., Sato, K., Arioka, M., Uchida, T. and Imahori, K. (1992) Phosphorylation sites on tau by tau protein kinase I, a bovine derived kinase generating an epitope of paired helical filaments. Neurosci. Lett. 148, 202-206
10. Ishiquro, K., Shiratsuchi, A., Sato, S., Omori, A., Arioka, M., Kobayashi, S., Uchida, T. and Imahori, K. (1993) Glycogen synthase kinase 3β is identical to tau protein kinase I generating several epitopes of paired helical filaments. FEBS Lett. 325, 167-172 (Pubitemid 23186470)
11. Yang, S. D., Song, J. S., Yu, J. S. and Shiah, S. G. (1993) Protein kinase Fa:GSK-3 phosphorylates tau on Ser235-Pro and Ser404-Pro that are abnormally phosphorylated in Alzheimer's disease brain. J. Neurochem. 61, 1742-1747
12. Takashima, A., Noguchi, K., Michel, G., Mercken, M., Hoshi, M., Ishiguro, K. and Imahori, K. (1996) Exposure of rat hippocampal neurons to amyloid β peptide (25-35) induces the inactivation of phosphatidylinositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3 β. Neurosci. Lett. 203, 33-36
13. Okawa, Y., Ishiguro, K. and Fujita, S. C. (2003) Stress-induced hyperphosphorylation of tau in the mouse brain. FEBS Lett. 535, 183-189
14. Lovestone, S., Reynolds, C. H., Latimer, D., Davis, D. R., Anderton, B. H., Gallo, J. M., Hanger, D., Mulot, S., Marquardt, B., Stabel, S. et al. (1994) Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Curr. Biol. 4, 1077-1086
15. Munoz-Montano, J. R., Moreno, F. J., Avila, J. and Diaz-Nido, J. (1997) Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons. FEBS Lett. 411, 183-188 (Pubitemid 27301451)
16. Hong, M., Chen, D. C., Klein, P. S. and Lee, V. M. (1997) Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3. J. Biol. Chem. 272, 25326-25332
17. Liu, S. J., Zhang, A. H., Li, H. L., Wang, O., Deng, H. M., Netzer, W, J., Xu, H. X. and Wang, J. Z. (2003) Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory. J. Neurochem. 87, 1333-1344
18. Mukai, F., Ishiguro, K., Sano, Y. and Fujita, S. C. (2002) Alternative splicing isoform of tau protein kinase I/glycogen synthase kinase 3β. J. Neurochem. 81, 1073-1083
19. Wood-Kaczmar, A., Kraus, M., Ishiguro, K., Philpott, K. L. and Gordon-Weeks, P. R. (2009) An alternatively spliced form of glycogen synthase kinase-3β is targeted to growing neurites and growth cones. Mol. Cell Neurosci. 42, 184-194
20. Ferrer, I., Barrachina, M. and Puig, B. (2002) Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathol. (Berlin) 104, 583-591
21. Pei, J. J., Braak, E., Braak, H., Grundke-Iqbal, I., Iqbal, K., Winblad, B. and Cowburn, R. F. (1999) Distribution of active glycogen synthase kinase 3β (GSK-3β) in brains staged for Alzheimer disease neurofibrillary changes. J. Neuropathol. Exp. Neurol. 58, 1010-1019
22. Jackson, G. R., Wiedau-Pazos, M., Sang, T. K., Wagle, N., Brown, C. A., Massachi, S. and Geschwind, D. H. (2002) Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron 34, 509-519
23. Wittmann, C. W., Wszolek, M. F., Shulman, J. M., Salvaterra, P. M., Lewis, J., Hutton, M. and Feany, M. B. (2001) Tauopathy in Drosophila : neurodegeneration without neurofibrillary tangles. Science 293, 711-714
24. Engel, T., Lucas, J. J., Gomez-Ramos, P., Moran, M. A., Avila, J. and Hernandez, F. (2006) Cooexpression of FTDP-17 tau and GSK-3β in transgenic mice induce tau polymerization and neurodegeneration Neurobiol. Aging 27, 1258-1268 (Pubitemid 44088576)
25. Wang, J. Z., Grundke-Iqbal, I. and Iqbal, K. (2007) Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. Eur. J. Neurosci. 25, 59-68
26. Liu, F., Grundke-Iqbal, I., Iqbal, K. and Gong, C. X. (2005) Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur. J. Neurosci. 22, 1942-1950
27. Gong, C. X., Singh, T. J., Grundke-Iqbal, I. and Iqbal, K. (1993) Phosphoprotein phosphatase activities in Alzheimer disease brain. J. Neurochem. 61, 921-927 (Pubitemid 23241228)
28. Leroy, K., Yilmaz, Z. and Brion, J. P. (2007) Increased level of active GSK-3β in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration. Neuropathol. Appl. Neurobiol. 33, 43-55
29. Hye, A., Kerr, F., Archer, N., Foy, C., Poppe, M., Brown, R., Hamilton, G., Powell, J., Anderton, B. and Lovestone, S. (2005) Glycogen synthase kinase-3 is increased in white cells early in Alzheimer's disease. Neurosci. Lett. 373, 1-4
30. Ren, Q. G., Liao, X. M., Wang, Z. F., Qu, Z. S. and Wang, J. Z. (2006) The involvement of glycogen synthase kinase-3 and protein phosphatase-2A in lactacystin-induced tau accumulation. FEBS Lett. 580, 2503-2511
31. Tsuji, S., Morinobu, S., Tanaka, K., Kawano, K. and Yamawaki, S. (2003) Lithium, but not valproate, induces the serine/threonine phosphatase activity of protein phosphatase 2A in the rat brain, without affecting its expression. J. Neural. Transm. 110, 413-425
32. Liu, G. P., Zhang, Y., Yao, X. Q., Zhang, C. E., Fang, J., Wang, Q. and Wang, J. Z. (2008) Activation of glycogen synthase kinase-3 inhibits protein phosphatase-2A and the underlying mechanisms. Neurobiol. Aging 29, 1348-1358
33. Chen, J., Martin, B. L. and Brautigan, D. L. (1992) Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation. Science 257, 1261-1264
34. Hoeflich, K. P., Luo, J., Rubie, E. A., Tsao, M. S, Jin, O. and Woodgett, J. R. (2000) Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation. Nature 406, 86-90
35. Kaspar, B. K., Vissel, B., Bengoechea, T., Crone, S., Randolph-Moore, L., Muller, R., Brandon, E. P., Schaffer, D., Verma, I. M., Lee, K. F. et al. (2002) Adeno-associated virus effectively mediates conditional gene modification in the brain. Proc. Natl. Acad. Sci. U.S.A. 99, 2320-2325
36. Liu, S. J., Zhang, A. H., Li, H. L., Wang, Q., Deng, H. M., Netzer, W. J., Xu, H. and Wang, J. Z. (2003) Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory. J. Neurochem. 87, 1333-1344
37. Venable, C. L., Frevert, E. U., Kim, Y. B., Fischer, B. M., Kamatkar, S., Neel, B. G. and Kahn, B. B. (2000) Overexpression of protein-tyrosine phosphatase-1B in adipocytes inhibits insulin-stimulated phosphoinositide 3-kinase activity without altering glucose transport or Akt/protein kinase B activation. J. Biol. Chem. 275, 18318-18326
38. Wang, J. Z., Grundke-Iqbal, I. and Iqbal, K. (1996) Restoration of biological activity of Alzheimer abnormally phosphorylated τ by dephosphorylation with protein phosphatase-2A, -2B and -1. Mol. Brain Res. 38, 200-208
39. Yamamoto, H., Hasegawa, M., Ono, T., Tashima, K., Ihara, Y. and Miyamoto, E. (1995) Dephosphorylation of fetal-tau and paired helical filament-tau by protein phosphatase 1 and 2A and calcineurin. J. Biochem. 118, 1224-1231
40. Sontag, E., Luangpirom, A., Hladik, C., Mudrak, I., Ogrisrd, E., Speciale, S. and White, 3rd, C. L. (2004) Altered expression levels of the protein phosphatase 2A ABαC enzyme are associated with Alzheimer disease pathology. J. Neuropathol. Exp. Neurol. 63, 287-301
41. Sontag, E., Hladik, C., Montgomery, L., Luangpirom, A., Mudrak, I., Ogris, E. and White, 3rd., C. L. (2004) Downregulation of protein phosphatase 2A carboxyl methylation and methyltransferase may contribute to Alzheimer disease pathogenesis. J. Neuropathol. Exp. Neurol. 63, 1080-1091
42. Tanimukai, H., Grundke-Iqbal, I. and Iqbal, K. (2005) Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease. Am. J. Pathol. 166, 1761-1771
43. Chen, J., Parsons, S. and Brautigan, D. L. (1994) Tyrosine phosphorylation of protein phosphatase 2A in response to growth stimulation and v-src transformation of fibroblasts. J. Biol. Chem. 269, 7957-7962
44. Shimizu, S., Ugi, S., Maegawa, H., Egawa, K., Nishio, Y., Yoshizaki, T., Shi, K., Nagai, Y., Morino, K., Nemoto, K. et al. (2003) Protein-tyrosine phosphatase 1B as new activator for hepatic lipogenesis via sterol regulatory element-binding protein-1 gene expression. J. Biol. Chem. 278, 43095-43101
45. Fischer, E. H., Charbonneau, H. and Tonks, N. K. (1991) Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes. Science 253, 401-406
46. Barford, D., Flint, A. J. and Tonks, N. K. (1994) Crystal structure of human protein tyrosine phosphatase 1B. Science 263, 1397-1404
47. Wang, Q., Somwar, R., Bilan, P. J., Liu, Z., Jin, J., Woodgett, J. R. and Klip, A. (1999) Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol. Cell. Biol. 19, 4008-4018
48. Ahmad, F. and Goldstein, B. J. (1995) Increased abundance of specific skeletal muscle protein-tyrosine phosphatases in a genetic model of insulin-resistant obesity and diabetes mellitus. Metabolism 44, 1175-1184 (Pubitemid 26084039)
49. Ahmad, F., Considine, R. V. and Goldstein, B. J. (1995) Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects. J. Clin. Invest. 95, 2806-2812
50. Yokoyama, N. and Miller, W. T. (2001) Inhibition of Src by direct interaction with protein phosphatase 2A. FEBS Lett. 505, 460-464
51. Brown, M. T. and Cooper, J. A. (1996) Regulation, substrates and functions of src. Biochim. Biophys. Acta. 1287, 121-149
52. Cooper, J. A. and Howell, B. (1993) The when and how of Src regulation. Cell 73, 1051-1054 (Pubitemid 23180479)
53. Roskoski, R. J. (2005) Src kinase regulation by phosphorylation and dephosphorylation. Biochem. Biophys. Res. Commun. 331, 1-14
54. Levin, V. A. (2004) Basis and importance of Src as a target in cancer. Cancer Treat. Res. 119, 89-119
55. Bjorge, J. D., Pang, A. and Fujita, D. J. (2000) Identification of protein-tyrosine phosphatase 1B as the major tyrosine phosphatase activity capable of dephosphorylating and activating c-Src in several human breast cancer cell lines. J. Biol. Chem. 275, 41439-41446
56. Khew-Goodall, Y., Mayer, R. E., Maurer, F., Stone, S. R. and Hemmings, B. A. (1991) Structure and transcriptional regulation of protein phosphatase 2A catalytic subunit genes. Biochemistry 30, 89-97
57. Jones, T. A., Barker, H. M., Da Cruz e Silva, E. F., Mayer-Jaekel, R. E., Hemmings, B. A., Spurr, N. K., Sheer, D. and Cohen, P. T. W. (1993) Localization of the genes encoding the catalytic subunits of protein phosphatase 2A to human chromosome bands 5q23-q31 and 8p12-p11. 2, respectively. Cytogenet. Cell Genet. 63, 35-41
58. Stone, S. R., Hofsteenge, J. and Hemmings, B. A. (1987) Molecular cloning of cDNAs encoding two isoforms of the catalytic subunit of protein phosphatase 2A. Biochemistry 26, 7215-7220
59. Green, D. D., Yang, S. I. and Mumby, M. C. (1987) Molecular cloning and sequence analysis of the catalytic subunit of bovine type 2A protein phosphatase. Proc. Natl. Acad. Sci. U.S.A. 84, 4880-4884
60. Arino, J., Woon, C. W., Brautigan, D. L. and Miller, Jr, T. B. (1988) Human liver phosphatase 2A: cDNA and amino acid sequence of two catalytic subunit isotypes. Proc. Natl. Acad. Sci. U.S.A. 85, 4252-4256
61. Khew-Goodall, Y. and Hemmings, B. A. (1988) Tissue-specific expression of mRNAs encoding a- and b-catalytic subunits of protein phosphatase 2A. FEBS Lett. 238, 265-268
62. Hooper, C., Killick, R. and Lovestone, S. (2008) The GSK3 hypothesis of Alzheimer's disease. J. Neurochem. 104, 1433-1439 (Pubitemid 351316776)
63. Leroy, K., Boutajangout, A., Authelet, M., Woodgett, J. R., Anderton, B. H. and Brion, J. P. (2002) The active form of glycogen synthase kinase-3β is associated with granulovacuolar degeneration in neurons in Alzheimer's disease. Acta Neuropathol. 103, 91-99
64. Pei, J. J., Gong, C. X., Iqbal, K., Grundke-Iqbal, I., Wu, Q. L., Winblad, B. and Cowburn, R. F. (1998) Subcellular distribution of protein phosphatases and abnormally phosphorylated tau in the temporal cortex from Alzheimer's disease and control brains. J. Neural. Transm. 105, 69-83
65. Vogelsberg-Ragaglia, V., Schuck, T., Trojanowski, J. Q. and Lee, V. M. (2001) PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus. Exp. Neurol. 168, 402-412
66. Liu, R., Zhou, X. W., Tanila, H., Bjorkdahl, C., Wang, J. Z., Guan, Z. Z., Cao, Y., Gustafsson, J. A., Winblad, B. and Pei, J. J. (2008) Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology. J. Cell Mol. Med. 12, 241-257